Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Liwei Biological Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and industrial-scale production of steroid hormone APIs and intermediates. Founded in 2001 and based in Neixiang, Henan Province, the company utilizes advanced fermentation and chemical synthesis technologies to produce a wide range of steroid products, including progesterone, testosterone, and spironolactone. Their manufacturing facilities are GMP-certified, and they are recognized as a key global supplier in the steroid hormone market. The company focuses on green chemistry, often deriving its products from plant-based phytosterols rather than traditional animal sources. Henan Liwei was previously listed on China's National Equities Exchange and Quotations (NEEQ), reflecting its established commercial presence. Their products serve various therapeutic areas, including reproductive health, endocrinology, and cardiovascular medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Henan Liwei Biological Pharmaceutical.